SZSunyun Zhang

Sunyun Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sunyun Zhang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Sheng Yang

    Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, China

    2 shared publications
  • Fan Yang

    Department of Thoracic Surgery, Peking University People’s Hospital, Beijing, China

    1 shared publication
  • Fang Yuan

    Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, Fujian, P.R. China

    1 shared publication
  • Nan Li

    Department of Chinese Medicine, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, Fujian, P.R. China

    1 shared publication
  • Qian Xu

    Departments of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, PR China

    1 shared publication
  • Qiong Luo

    Department of Oncology, Fujian Medical University Union Hospital, Fujian Medical University Fuzhou, Fujian, P.R. China

    1 shared publication

Latest Publications

  • The Therapeutic Effects of Dihydroartemisinin on Cisplatin-Resistant Gastric Cancer Cells

    by Suyun Zhang, Rui Feng, Fang Yuan, Qiong Luo, Xiangqi Chen, Nan Li, Sheng Yang

    Background: Dihydroartemisinin (DHA) exhibited anti-tumor effect in a variety of cancer cells, but its mechanism of action is unclear. Objective: To investigate the therapeutic effects of DHA on Cisplatin (DDP)-resistant gastric cancer cell strain SGC7901/DDP and the possible molecular mechanism. Methods: Cells were treated with DHA in a dose- and time-dependent manner, after which their proliferation, apoptosis, invasion, and migration abilities were evaluated. We further evaluated autophagy with mRFP-GFP-LC3 adenovirus transfection and transmission electron microscopy and also detected the expression levels of proteins (related to autophagy and apoptosis) via western blot. Meanwhile, the influence of DHA on cisplatin resistance was detected through a sensitization test and the evaluation of P-gp expression levels. Results: DHA effectively inhibited the proliferation, invasion, and migration of SGC7901/DDP cells and induced cell apoptosis which was accompanied by caspase-8/9/3 activation. Furthermore, exposure to DHA resulted in a pronounced increase in autophagy proteins, including Beclin-1 and LC3 II with PI3K/AKT/mTOR pathway inhibition. Additionally, enhancement of cisplatin sensitivity occurred in SGC7901/DDP cells treated with DHA, which was accompanied by P-gp downregulation. Conclusion: DHA exerts an anti-cancer effect on SGC7901/DDP cells and the mechanisms possibly include enhancement of autophagy via PI3K/AKT/mTOR inhibition, inducement of apoptosis through caspase-dependent and mitochondrial pathway, and enhancement of cisplatin sensitivity through P-gp inhibition.


  • Open Access

    ADP ribosylation factor guanylate kinase 1 promotes the malignant phenotype of gastric cancer by regulating focal adhesion kinase activation

    by Sunyun Zhang, Qiong Luo, Rui Feng, Fan Yang, Qian Xu, Xiangqi Chen, Sheng Yang